TG Therapeutics, Inc. (TGTX)
30.57
-0.14
(-0.46%)
USD |
NASDAQ |
Jan 16, 16:00
30.80
+0.23
(+0.75%)
After-Hours: 20:00
TG Therapeutics Shareholders Equity (Quarterly): 607.22M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| MannKind Corp. | -44.55M |
| Karyopharm Therapeutics, Inc. | -269.26M |
| Axsome Therapeutics, Inc. | 73.73M |
| Krystal Biotech, Inc. | 1.138B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.025B |
| Total Liabilities (Quarterly) | 417.81M |
| Debt to Equity Ratio | 0.4178 |
| Current Ratio | 3.825 |
| Net Debt Paydown Yield | -0.50% |